These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31889506)

  • 1. Environmental Predictors of Schistosomiasis Persistent Hotspots following Mass Treatment with Praziquantel.
    Walker JW; Kittur N; Binder S; Castleman JD; Drake JM; Campbell CH; King CH; Colley DG
    Am J Trop Med Hyg; 2020 Feb; 102(2):328-338. PubMed ID: 31889506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent Hotspots in Schistosomiasis Consortium for Operational Research and Evaluation Studies for Gaining and Sustaining Control of Schistosomiasis after Four Years of Mass Drug Administration of Praziquantel.
    Kittur N; King CH; Campbell CH; Kinung'hi S; Mwinzi PNM; Karanja DMS; N'Goran EK; Phillips AE; Gazzinelli-Guimaraes PH; Olsen A; Magnussen P; Secor WE; Montgomery SP; Utzinger J; Walker JW; Binder S; Colley DG
    Am J Trop Med Hyg; 2019 Sep; 101(3):617-627. PubMed ID: 31287046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovering, Defining, and Summarizing Persistent Hotspots in SCORE Studies.
    Kittur N; Campbell CH; Binder S; Shen Y; Wiegand RE; Mwanga JR; Kinung'hi SM; Musuva RM; Odiere MR; Matendechero SH; Knopp S; Colley DG
    Am J Trop Med Hyg; 2020 Jul; 103(1_Suppl):24-29. PubMed ID: 32400365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Approaches to Predicting Persistent Hotspots in SCORE Studies for Gaining Control of Schistosomiasis Mansoni in Kenya and Tanzania.
    Shen Y; Sung MH; King CH; Binder S; Kittur N; Whalen CC; Colley DG
    J Infect Dis; 2020 Feb; 221(5):796-803. PubMed ID: 31621850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reinfection with Schistosoma haematobium following school-based chemotherapy with praziquantel in four highly endemic villages in Côte d'Ivoire.
    N'Goran EK; Utzinger J; N'Guessan AN; Müller I; Zamblé K; Lohourignon KL; Traoré M; Sosthène BA; Lengeler C; Tanner M
    Trop Med Int Health; 2001 Oct; 6(10):817-25. PubMed ID: 11679130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) - single versus multiple praziquantel treatments in school-aged children in Côte d'Ivoire: a study protocol for an open-label, randomised controlled trial.
    Hoekstra PT; Casacuberta Partal M; Amoah AS; van Lieshout L; Corstjens PLAM; Tsonaka S; Assaré RK; Silué KD; Meité A; N'Goran EK; N'Gbesso YK; Roestenberg M; Knopp S; Utzinger J; Coulibaly JT; van Dam GJ
    BMC Infect Dis; 2018 Dec; 18(1):662. PubMed ID: 30547750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining Persistent Hotspots: Areas That Fail to Decrease Meaningfully in Prevalence after Multiple Years of Mass Drug Administration with Praziquantel for Control of Schistosomiasis.
    Kittur N; Binder S; Campbell CH; King CH; Kinung'hi S; Olsen A; Magnussen P; Colley DG
    Am J Trop Med Hyg; 2017 Dec; 97(6):1810-1817. PubMed ID: 29016344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthelminthic treatment receipt and its predictors in Lake Victoria fishing communities, Uganda: Intervention coverage results from the LaVIISWA cluster randomised trial.
    Akurut H; Sanya RE; Lubyayi L; Nampijja M; Kizza M; Kaweesa J; Kizindo R; Sewankambo M; Nsubuga D; Tukahebwa E; Kabatereine NB; Elliott AM; Webb EL;
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008718. PubMed ID: 33075067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of School-Based and Community-Wide Mass Drug Administration for Schistosomiasis Control in an Area of Western Kenya with High Initial
    Secor WE; Wiegand RE; Montgomery SP; Karanja DMS; Odiere MR
    Am J Trop Med Hyg; 2020 Feb; 102(2):318-327. PubMed ID: 31802733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gaining and sustaining schistosomiasis control: study protocol and baseline data prior to different treatment strategies in five African countries.
    Ezeamama AE; He CL; Shen Y; Yin XP; Binder SC; Campbell CH; Rathbun S; Whalen CC; N'Goran EK; Utzinger J; Olsen A; Magnussen P; Kinung'hi S; Fenwick A; Phillips A; Ferro J; Karanja DM; Mwinzi PN; Montgomery S; Secor WE; Hamidou A; Garba A; King CH; Colley DG
    BMC Infect Dis; 2016 May; 16():229. PubMed ID: 27230666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons Learned in Conducting Mass Drug Administration for Schistosomiasis Control and Measuring Coverage in an Operational Research Setting.
    Binder S; Campbell CH; Castleman JD; Kittur N; Kinung'hi SM; Olsen A; Magnussen P; Karanja DMS; Mwinzi PNM; Montgomery SP; Secor WE; Phillips AE; Dhanani N; Gazzinelli-Guimaraes PH; Clements MN; N'Goran EK; Meite A; Utzinger J; Hamidou AA; Garba A; Fleming FM; Whalen CC; King CH; Colley DG
    Am J Trop Med Hyg; 2020 Jul; 103(1_Suppl):105-113. PubMed ID: 32400352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interrupting seasonal transmission of Schistosoma haematobium and control of soil-transmitted helminthiasis in northern and central Côte d'Ivoire: a SCORE study protocol.
    Tian-Bi YT; Ouattara M; Knopp S; Coulibaly JT; Hürlimann E; Webster B; Allan F; Rollinson D; Meïté A; Diakité NR; Konan CK; N'Goran EK; Utzinger J
    BMC Public Health; 2018 Jan; 18(1):186. PubMed ID: 29378542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustaining control of schistosomiasis mansoni in moderate endemicity areas in western Côte d'Ivoire: a SCORE study protocol.
    Assaré RK; Knopp S; N'Guessan NA; Yapi A; Tian-Bi YN; Yao PK; Coulibaly JT; Ouattara M; Meïté A; Fenwick A; N'Goran EK; Utzinger J
    BMC Public Health; 2014 Dec; 14():1290. PubMed ID: 25519880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCORE Operational Research on Moving toward Interruption of Schistosomiasis Transmission.
    Campbell CH; Binder S; King CH; Knopp S; Rollinson D; Person B; Webster B; Allan F; Utzinger J; Ame SM; Ali SM; Kabole F; N'Goran EK; Tediosi F; Salari P; Ouattara M; Diakité NR; Hattendorf J; S Andros T; Kittur N; Colley DG
    Am J Trop Med Hyg; 2020 Jul; 103(1_Suppl):58-65. PubMed ID: 32400354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: a spatiotemporal modelling study.
    Kokaliaris C; Garba A; Matuska M; Bronzan RN; Colley DG; Dorkenoo AM; Ekpo UF; Fleming FM; French MD; Kabore A; Mbonigaba JB; Midzi N; Mwinzi PNM; N'Goran EK; Polo MR; Sacko M; Tchuem Tchuenté LA; Tukahebwa EM; Uvon PA; Yang G; Wiesner L; Zhang Y; Utzinger J; Vounatsou P
    Lancet Infect Dis; 2022 Jan; 22(1):136-149. PubMed ID: 34863336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Praziquantel-related visual disorders among recipients in mass drug administration campaigns in schistosomiasis endemic settings: Systematic review and meta-analysis protocol.
    Danso-Appiah A; Owiredu D; Akuffo KO
    PLoS One; 2024; 19(5):e0300384. PubMed ID: 38758736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.
    Phillips AE; Gazzinelli-Guimaraes PH; Aurelio HO; Ferro J; Nala R; Clements M; King CH; Fenwick A; Fleming FM; Dhanani N
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006061. PubMed ID: 29220347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in Protocol Development and Interpretation of the Schistosomiasis Consortium for Operational Research and Evaluation Intervention Studies.
    King CH; Kittur N; Wiegand RE; Shen Y; Ge Y; Whalen CC; Campbell CH; Hattendorf J; Binder S
    Am J Trop Med Hyg; 2020 Jul; 103(1_Suppl):36-41. PubMed ID: 32400342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive impact of preventative chemotherapy during a national helminth control program: Perception and KAP.
    Mutapi F; Tagwireyi P; Lim R; Mangwanda B; Fourier C; Mduluza T
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008494. PubMed ID: 32833994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the uptake of preventive chemotherapy treatment for schistosomiasis in Sub-Saharan Africa: A systematic review.
    Torres-Vitolas CA; Dhanani N; Fleming FM
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0009017. PubMed ID: 33465076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.